Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial

Danijela Tatović(Cardiff University), Laura Cook(University of British Columbia), Rakesh Amin(University College London), Megan K. Levings(University of British Columbia), Fiona Campbell(Leicester Royal Infirmary), Simi Ahmed(Breakthrough T1D), Eleni Christakou(King's College London), Kymberley Carter(Swansea University), Jane Bowen‐Morris(Cardiff University), Colin Dayan(University of Birmingham), Evangelia Williams(King's College London), Stephanie Hanna(Cardiff University), Yasaman Shahrabi(King's College London), Emma Webb(University of East Anglia), Steve Hiles(Swansea University), Mimi Chen(Tianjin University), Jan Dutz(BC Children's Hospital), Susie Marques-Jones, Evelien Gevers(Queen Mary University of London), Rachel Stenson(Cardiff University), Peter Taylor(University Hospital of Wales), Gareth Dunseath(University Hospital Llandough), Timothy Tree(King's College London), Michal Ajzensztejn(Royal Belfast Hospital for Sick Children), WY Cheung(Swansea University), Muntaha Wadud(Guy's Hospital), Jennie H. M. Yang(Mayo Clinic), John W Gregory(Cardiff University), Greg Fegan(Kenya Medical Research Institute), Kamila Sychowska(King's College London), Emily Pollock(Guy's Hospital), Kirsten A. Ward‐Hartstonge(University of British Columbia), Ashish Marwaha(University of Calgary), Hayley Hutchings(Swansea University), Christina Wei, Chris Mouditis(Royal Devon and Exeter Hospital), Maximilian Robinson(King's College London), Sunil Nair(Countess of Chester Hospital NHS Foundation Trust), Nicholas Conway, James Greening(Norfolk and Norwich University Hospital), Chris Gardner(Evelina London Children's Healthcare), Ambika Shetty(Swansea Bay University Health Board), B. White(Noah's Ark Children's Hospital for Wales), Gail Holland(Swansea University), Shankar Kanumakala(University of Liverpool), Clara Domingo‐Vila(King's College London)
Nature Medicine
July 30, 2024
Cited by 40


Related Papers